Filgrastim Recruiting Phase 2 Trials for Hematopoietic Stem Cell Transplantation (HSCT) / Graft Failure / Wiskott-Aldrich Syndrome (WAS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03019809A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients